Safety of COVID-19 Vaccination in Immune-Deficient Patients Receiving Supplemental Immunoglobulin Therapies.

Squire, Jacqueline D; Joshi, Avni Y

Squire, Jacqueline D; Joshi, Avni Y.

Squire JD; Division of Pulmonary, Allergy, and Sleep Medicine, Mayo Clinic, Jacksonville, FL, USA. Squire.Jacqueline@mayo.edu.
Joshi AY; Division of Pediatric Allergy & Immunology, Mayo Clinic Children's Center, Rochester, MN, USA.

J Clin Immunol ; 41(7): 1527-1530, 2021 Oct.

Article in English | MEDLINE | ID: covidwho-1320114

Subject(s)

COVID-19 Vaccines/immunology; COVID-19/immunology; COVID-19/therapy; Immunologic Deficiency Syndromes/immunology; SARS-CoV-2/physiology; Adolescent; Adult; Aged; Aged, 80 and over; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Immunization, Passive; Immunologic Deficiency Syndromes/therapy; Male; Middle Aged; Vaccination; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Immunologic Deficiency Syndromes Topics: Vaccines Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged / Young adult Language: English Journal: J Clin Immunol Year: 2021 Document Type: Article Affiliation country: S10875-021-01101-8

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google